What are the current clinical guidelines for managing chemotherapy-induced peripheral neuropathy?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18386229
Cited by: 0

Abstract

Duloxetine is the primary agent recommended for managing painful CIPN, while structured exercise programs and complementary therapies like acupuncture show promise in alleviating symptoms and improving quality of life.

Fields of Study & Subjects

Cancer Treatment and Pharmacology Chemotherapy-related skin toxicity Cancer survivorship and care

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 January 2026